Lee Youngok, Cho Joon Yong, Kwon O Young, Jang Woo Sung
Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine.
Korean J Thorac Cardiovasc Surg. 2016 Oct;49(5):337-343. doi: 10.5090/kjtcs.2016.49.5.337. Epub 2016 Oct 5.
Recent developments in surgical techniques and hospital care have led to improved outcomes following total anomalous pulmonary venous return (TAPVR) repair. However, the surgical repair of TAPVR remains associated with a high risk of mortality and need for reoperation. We conducted this retrospective study to evaluate mid-term outcomes following TAPVR repair without total circulatory arrest (TCA), and to identify the risk factors associated with surgical outcomes.
We retrospectively reviewed 29 cases of surgical intervention for TAPVR conducted between April 2000 and July 2015. All patients were newborns or infants who underwent TAPVR repair without TCA.
Four anatomic subtypes of TAPVR were included in this study: supracardiac (20 cases, 69.0%), cardiac (4 cases, 13.8%), infracardiac (4 cases, 13.8%), and mixed (1 case, 3.4%). The median follow-up period for all patients was 42.9 months. Two (6.9%) early mortalities occurred, as well as 2 (6.9%) cases of postoperative pulmonary venous obstruction (PVO). Preoperative ventilator care (p=0.027) and preoperative PVO (p=0.002) were found to be independent risk factors for mortality.
repair of TAPVR without TCA was associated with encouraging mid-term outcomes. Preoperative ventilator care and preoperative PVO were found to be independent risk factors for mortality associated with TAPVR repair.
外科技术和医院护理方面的最新进展已使完全性肺静脉异位引流(TAPVR)修复术后的预后得到改善。然而,TAPVR的外科修复仍与高死亡率和再次手术需求相关。我们进行了这项回顾性研究,以评估非体外循环下TAPVR修复术后的中期预后,并确定与手术结果相关的危险因素。
我们回顾性分析了2000年4月至2015年7月间进行的29例TAPVR外科干预病例。所有患者均为新生儿或婴儿,接受了非体外循环下的TAPVR修复术。
本研究纳入了TAPVR的四种解剖亚型:心上型(20例,69.0%)、心内型(4例,13.8%)、心下型(4例,13.8%)和混合型(1例,3.4%)。所有患者的中位随访期为42.9个月。发生了2例(6.9%)早期死亡,以及2例(6.9%)术后肺静脉梗阻(PVO)病例。术前机械通气治疗(p=0.027)和术前PVO(p=0.002)被发现是死亡的独立危险因素。
非体外循环下TAPVR修复术具有令人鼓舞的中期预后。术前机械通气治疗和术前PVO被发现是与TAPVR修复术相关的死亡独立危险因素。